Improving Drop Instillation Comfort of a Cyclosporine A Solution
Dry Eye Disease
About this trial
This is an interventional supportive care trial for Dry Eye Disease focused on measuring dry eye disease, cyclosporine, eye drop
Eligibility Criteria
Inclusion Criteria: Over 18 years of age. Ocular Surface Disease Index score >= 23. Strip meniscometry < 5 mm. Exclusion Criteria: Contact lens wearers. Have corneal neuropathic or neurotrophic disease. Have an ocular or medical condition or taking medications that could confound a study outcome. Currently pregnant or breastfeeding (cyclosporine is a FDA pregnancy Category C drug). Have an ocular or medical condition for which Cequa is contraindicated (e.g., allergy to cyclosporine or other ingredients in Cequacurrent eye infection, cancer or precancerous condition in or around the eyes). Have an allergy to fluorescein.
Sites / Locations
- University of WaterlooRecruiting
Arms of the Study
Arm 1
Experimental
All participants
All participants will have a refrigerated 0.09% cyclosporine drop instilled in one eye, and a non-refrigerated 0.09% cyclosporine drop instilled in the other eye. The eye that receives the refrigerated drop is randomly determined.